Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029380 | SCV000052028 | benign | Wilson disease | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Prevention |
RCV000242632 | SCV000301726 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000242632 | SCV000526109 | benign | not specified | 2016-05-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000029380 | SCV000626864 | benign | Wilson disease | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000029380 | SCV001267647 | benign | Wilson disease | 2018-08-30 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
ARUP Laboratories, |
RCV000029380 | SCV001471683 | benign | Wilson disease | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326687 | SCV002626755 | benign | Inborn genetic diseases | 2017-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000029380 | SCV004361950 | likely benign | Wilson disease | 2022-06-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000029380 | SCV004844509 | likely benign | Wilson disease | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001579911 | SCV005215646 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000029380 | SCV001453575 | benign | Wilson disease | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579911 | SCV001808992 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000242632 | SCV001917118 | benign | not specified | no assertion criteria provided | clinical testing |